← Eichor
Study identifier: NCT06631378 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Transverse Versus Longitudinal Groin Incision in Vascular Surgery

Condition: Peripheral Arterial Disease(PAD) · Aneurysmal Disease  ·  Sponsor: Kolding Sygehus

PhaseNA
Planned participants232
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery. The main questions it aims to answer are: Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal incision? Does a transverse incision lead to fewer readmissions, fewer reoperations, shorter length of hospital stay, and a lower amputation rate. Participants will undergo vascular surgery in the groin with either a transverse or longitudinal incision. The incision type will be selected randomly.

This description comes directly from the study's public registry record.

Talk to the study team

Christina P Madsen, Dr  ·  +4576360788  ·  christina.pilgaard.madsen@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Vascular Surgery - Lillebaelt HospitalKolding, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06631378